The story
In October 1943, Albert Schatz, a graduate student in Selman Waksman's laboratory at Rutgers University in New Jersey, isolated streptomycin from a soil microbe, Streptomyces griseus. It was the first effective antibiotic against tuberculosis, one of the leading causes of death in the United States at the start of the 20th century. Penicillin did not work against the tuberculosis bacillus, so doctors had little to offer beyond rest in sanatoriums.
Waksman had been screening soil microbes for years for substances that kill bacteria, and he coined the word 'antibiotic' in 1942. His lab built on Alexander Fleming's penicillin and on the wartime push for new drugs. Schatz isolated strains of the microbe, and tests at the Mayo Clinic by William Feldman and Corwin Hinshaw showed that streptomycin cured tuberculosis in guinea pigs. In 1944 the first patient, a young woman with advanced disease, was treated and recovered. Resistance soon appeared when the drug was used alone, so doctors combined it with other drugs. A British Medical Research Council trial, published in 1948, tested it against bed rest in one of the first randomized clinical trials. Waksman alone received the 1952 Nobel Prize, and Schatz sued over credit and won a legal settlement that recognized him as co-discoverer.
Why it mattered
- Tuberculosis became curable, and the sanatorium era ended.
- The streptomycin trial helped establish the randomized controlled trial as the standard for testing medicines.
- Soil microbes became a major source of antibiotics, leading to drugs such as tetracycline and erythromycin.
- Resistance to the drug revealed the need for combination therapy, now standard in tuberculosis treatment.
Sources
- Streptomycin discovery Rutgers Waksman Museum
- Etymologia: Streptomycin Emerging Infectious Diseases (CDC)
- The Discovery of Streptomycin The Scientist
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…